From: Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study
Clinical course
CR1
CR2
CR2, CNS relapse and death
Resistant and death
Total
P
t (12; 21) at Remission (MRD)
Yes
12
2
1
-
15
0.01
No
6
9
18
11
30